Dr. Omar Abdul-Rahman is an ABMGG-certified clinical geneticist with nearly two decades of experience in pediatric, adult, and prenatal genetics. He has practiced since 2005 and has worked extensively with genetic counselors across multiple clinical settings.

From 2019 to 2023, Dr. Rahman was the founding Medical Director of the genetic counseling program at the University of Nebraska Medical Center (UNMC), where he also served as faculty in the ACGME-accredited medical genetics residency. He previously held leadership roles including Associate Program Director for Pediatrics, Vice Chair for Faculty Development, and Division Chief and Department Director of Medical Genetics at two institutions.

Currently, Dr. Rahman is Chief of Medical Genetics in Pediatrics at Weill Cornell Medicine and Co-Medical Director of the Weill Cornell Genetic Counseling Program. He has served on the USMLE Pharmacology/Biochemistry Test Material Development Committee for 10 years, co-chairing it for four years, and is a member of the Board of Directors of FASD United.

In education, Dr. Rahman has taught genetics to first-year medical, nursing, and pharmacy students, pediatric residents, and fellows, as well as genetic counseling students in both classroom and clinical settings.

Navpreet is a clinical genetic counselor who received her Master's of Genetic Counseling degree from the Icahn School of Medicine at Mount Sinai. She currently provides genetic counseling services in the Brooklyn Methodist Pediatric and Ob/gyn Departments, as well as the specialty Hemophilia Clinic at Weill Cornell.

Sarah Kane is a Senior Genetic Counselor at Memorial Sloan Kettering Cancer Center (MSKCC) with over 10 years of experience in clinical cancer genetic counseling. Sarah graduated from the Boston University School of Medicine Genetic Counseling program in 2015. Prior to joining MSKCC, Sarah was an adult and pediatric cancer genetic counselor at Dana Farber Cancer Institute. During her career, Sarah has provided clinical supervision and research mentorship to M.S Genetic Counseling students from various training programs. Sarah’s clinical expertise is focused on hereditary gastrointestinal cancer syndromes, such as Lynch syndrome and hereditary polyposis conditions, and on the integration of tumor-normal sequencing into routine clinical care for patients with cancer.

Ji-Sun earned her Bachelor's and Master's degrees from the University of Toronto in Canada, followed by a Master’s of Genetic Counseling from Sarah Lawrence College. Before joining the Weill Cornell Neurogenetics team, she worked as a pediatric genetic counselor at Rutgers University Hospital in New Jersey.

She has supervised numerous genetic counseling students and completed a certificate in genomic counseling and variant interpretation. Ji-Sun is actively involved in research on rare genetic variants through sequencing at the Center for Neurogenetics at Weill Cornell Medicine. She also participates in the Volare Study, a natural history study of rare neurodevelopmental disorders led by pediatric neurologist Dr. Zachary Grinspan. This study aims to gather essential data on rare neurological diseases to support the development of future clinical trials and therapies, laying the necessary groundwork for future clinical trials of therapies.

Shenela Lakhani is a dedicated professional with a passion for education and genetic counseling. With 15 years of clinical and research experience in genetic counseling, she specializes in rare diseases within the field of neurogenetics. As a recognized leader in global medicine and the founding director of the Weill Cornell Master of Science in Genetic Counseling Program, Shenela is committed to advancing the field and making a meaningful impact through her work.

Amanda is a Certified Genetic Counselor with over 13 years of extensive experience in direct patient care, program management, and genetic risk assessment. While her primary expertise lies in oncology, she has also provided counseling for prenatal, preconception, and cardiogenetic indications, and served as the genetic counselor for the Cystic Fibrosis Center at Good Samaritan Hospital. Throughout her career, Amanda has supervised more than 25 students during their clinical rotations in accredited genetic counseling programs, drawing on her comprehensive background to advance psychosocially attuned care, precise risk assessment, medical management planning, and genetics education.

Michelle Primiano is the Associate Director of Clinical Operations for the Genetics and Personalized Cancer Prevention Program and an Instructor of Human Genetics in Radiology at Weill Cornell Medicine. A board-certified genetic counselor with over a decade of experience in clinical genetics, she focuses on optimizing the delivery of cancer genomic services and implementing precision medicine to enhance patient care. She holds advanced certifications in pharmacogenomics and cancer risk assessment and has published in leading journals, including Genetics in Medicine and the American Journal of Human Genetics. Michelle has served in educational leadership roles in genetic counseling, with a focus on educational pedagogy, curriculum development, and graduate-level instruction. Michelle actively contributes to genetic counseling education and policy through her roles with the Genetic Counselor Educators Association and the New York State Genetics Task Force. At Weill Cornell Medicine, she supports program development, admissions, and institutional initiatives on health equity and precision medicine.

Dr. Ross received her MD and PhD from Cornell University Medical College her Neurology residency at Massachusetts General Hospital and molecular genetic fellowships at MGH and Rockefeller University. She built her laboratory at University of Minnesota before returning to Weill Cornell Medicine as a tenured Professor.  She is a physician scientist who leads the Laboratory of Neurogenetics and Development. Common threads in her work have been discovery of gene mutations causing neurological disorders as a window on the drivers of brain development and function.  The Center for Neurogenetics at WCM that she directs has both basic science and clinical arms, and operates a patient DNA and cell biobank. Dr. Ross has devoted much of her career to medical and neuroscience education. While at the University of Minnesota, she directed the NIH funded MD-PhD training program. At Weill Cornell Medicine she is Chair of the Neuroscience Graduate Program and is the founding Chair of the Master of Science in Genetic Counseling program.

Francesca has over 10 years of experience providing cancer genetic counseling at Weill Cornell Medicine.  From the inception of her position at Cornell, Francesca has been pivotal in the development and ongoing management of the Clinical Hereditary GI Cancers Registry. This Registry is a multidisciplinary clinical program with the goal of prevention and early detection of cancer for patients with significantly increased cancer risk through ongoing case review, personalized care plans, and care coordination. Her work strives to constantly improve the overall health and longevity of individuals with hereditary cancer syndromes. Francesca contributes to several research initiatives, and she has served as a rotation supervisor, teacher, and research mentor for numerous genetic counseling and other healthcare provider trainees with the goal of building a well-trained medical professional community. Francesca previously served as an Adjunct Professor at Long Island University-Post within their Genetic Counseling Graduate Program, and she has also been invited to speak for various local, regional, and national conferences.

Sarah is a cancer genetic counselor who received her Master's of Genetic Counseling degree from the Icahn School of Medicine at Mount Sinai. She specializes in inherited cancer predisposition and provides genetic counseling services in the Breast Center at New York-Presbyterian Queens for both patients with personal history of cancer and those at increased risk based on family history.